[Typical risks in the treatment of arrhythmias].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D003951:Diagnostic Errors; D004206:Disopyramide / Q000009:adverse effects; D004347:Drug Interactions; D006801:Humans; D012306:Risk; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D014700:Verapamil; D004206:Disopyramide
Typische Risiken bei der Behandlung von Herzrhythmusstörungen.